Evid Invest
Who owns XFORWhat XFOR owns — n/a

Who owns X4 Pharmaceuticals, Inc?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of XFOR from SEC Form 13F filings across 96 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 96 institutions disclosed 105.0M shares of X4 Pharmaceuticals, Inc worth $304.5M — about 83% of shares outstanding; the largest disclosed holder is MORGAN STANLEY. Source: SEC Form 13F filings, parsed by EvidInvest.

96

13F holders

$304.5M

value, 2026 filers

83%

of shares outstanding (105.0M sh)

14

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of XFOR's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1MORGAN STANLEY11.0M$31.9M0.0%8.7%+16.2%
2Empery Asset Management, LP9.7M$28.2M29.2%7.7%+40.3%
3Bain Capital Life Sciences Investors, LLC8.0M$23.1M1.6%6.3%0.0%
4Venrock Adviser, LLC7.6M$22.2M1.1%6%+295.2%
5Saturn V Capital Management LP7.4M$21.4M3.1%5.8%+5.6%
6PERCEPTIVE ADVISORS LLC7.4M$21.3M0.4%5.8%-7.3%
7BlackRock, Inc.5.9M$17.0M0.0%4.6%+5.4%
8FMR LLC5.5M$15.9M0.0%4.3%-34.0%
9Deep Track Capital, LP4.5M$13.1M0.2%3.6%-23.4%
10Kalehua Capital Management LLC3.7M$10.8M8.2%2.9%0.0%
11VANGUARD CAPITAL MANAGEMENT LLC3.6M$10.3M0.0%2.8%-4.2%
12Rosalind Advisors, Inc.3.2M$9.3M3.0%2.5%0.0%
13Trails Edge Capital Partners, LP2.6M$7.5M1.1%2%0.0%
14Nantahala Capital Management, LLC2.4M$7.1M0.2%1.9%0.0%
15Blackstone Inc.2.4M$7.0M0.0%1.9%-9.5%
16BRAIDWELL LP2.3M$6.8M0.3%1.9%-19.8%
17GOLDMAN SACHS GROUP INC2.3M$6.8M0.0%1.8%+154.8%
18Affinity Asset Advisors, LLC2.1M$6.0M0.2%1.6%+1322.4%
19GEODE CAPITAL MANAGEMENT, LLC2.0M$5.9M0.0%1.6%-2.4%
20STATE STREET CORP1.7M$5.0M0.0%1.4%+33.5%
21BVF INC/IL1.6M$4.6M0.2%1.2%-29.4%
22SAMSARA BIOCAPITAL, LLC1.3M$3.9M0.4%1.1%-3.4%
23Woodline Partners LP1.0M$2.9M0.0%0.8%0.0%
24NORTHERN TRUST CORP627,744$1.8M0.0%0.5%-3.8%
25VANGUARD PORTFOLIO MANAGEMENT LLC572,106$1.7M0.0%0.5%+5.5%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.